Citation Impact
Citing Papers
Microbiological Hazards Related to Xenotransplantation of Porcine Organs Into Man
2009
Humanized antibodies
1993 StandoutNobel
Vaccines and cytokine-mediated pathology in RSV infection
1994 StandoutNobel
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
1990
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The antiviral activity of antibodies in vitro and in vivo
2001
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins
1993
Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity
2008 StandoutNobel
Dexamethasone inhibits virus production and the secretory IgA response in oesophageal–pharyngeal fluid in cattle persistently infected with foot-and-mouth disease virus
1997
Nrf2 protects against airway disorders
2009
Detection of human respiratory syncytial virus genotype specific antibody responses in infants
2004
Building antibodies from their genes
1993 StandoutNobel
Antibody framework residues affecting the conformation of the hypervariable loops
1992 StandoutNobel
Biomedical applications of biodegradable polymers
2011 Standout
Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection in Vivo
1991
Respiratory Syncytial Virus–Induced Activation of Nuclear Factor–κB in the Lung Involves Alveolar Macrophages and Toll‐Like Receptor 4–Dependent Pathways
2002
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Bovine Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Cooperatively Antagonize Alpha/Beta Interferon-Induced Antiviral Response
2000
Building Antibodies from their Genes
1992 StandoutNobel
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
1992 StandoutNobel
Primary respiratory syncytial virus infection in mice
1988
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
2016 Standout
RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.
1989
Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses
1990 StandoutNobel
Humanized antibodies
1993 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.
1982
Induction of cytokines in mice with parainfluenza pneumonia
1995 StandoutNobel
Replication of an enteric bovine coronavirus in intestinal organ cultures
1978
Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice
1987
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
1986 Standout
Foot-and-Mouth Disease
2004 Standout
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
2020 Standout
Bee declines driven by combined stress from parasites, pesticides, and lack of flowers
2015 StandoutScience
Respiratory Syncytial Viral Infection in Children with Compromised Immune Function
1986
Role of Alpha/Beta Interferons in the Attenuation and Immunogenicity of Recombinant Bovine Respiratory Syncytial Viruses Lacking NS Proteins
2003
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice
1987
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Respiratory Syncytial Virus (RSV) Nonstructural (NS) Proteins as Host Range Determinants: a Chimeric Bovine RSV with NS Genes from Human RSV Is Attenuated in Interferon-Competent Bovine Cells
2002
Pulmonary IL‐33 orchestrates innate immune cells to mediate respiratory syncytial virus‐evoked airway hyperreactivity and eosinophilia
2019
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells
1992
Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody
1990
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin
2001
Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice
1987
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
1986
The scanning model for translation: an update.
1989 Standout
Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology
2009
Small Animal Models of Respiratory Viral Infection Related to Asthma
2018
Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice
2009
Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.
1999 Standout
Works of A.P. Collins being referenced
Virological Studies on an Experimental Minimal Disease Herd of Pigs
1971
The characterization and uses of monoclonal antibodies to respiratory syncytial virus.
1984
Infection of gnotobiotic calves with a bovine and human isolate of respiratory syncytial virus. Modification of the response by dexamethasone
1984
Respiratory syncytial virus infection in mice
1984
Monoclonal antibodies protect against respiratory syncytial virus infection in mice.
1984
Growth of Porcine Transmissible Gastroenteritis (TGE) Virus in Organ Cultures of Pig Tissue
1970 Nature
A comparison of three vaccines against respiratory syncytial virus in calves
1984
The possible role of respiratory syncytial virus and Pasteurella spp in calf respiratory disease
1980